Identification of Patients at Risk for Hereditary Colorectal Cancer

Abstract

Diagnosis of hereditary colorectal cancer syndromes requires clinical suspicion and knowledge of such syndromes. Lynch syndrome is the most common cause of hereditary colorectal cancer. Other less common causes include familial adenomatous polyposis (FAP), Peutz-Jeghers syndrome (PJS), juvenile polyposis syndrome, and others. There have been a growing number of clinical and molecular tools used to screen and test at risk individuals. Screening tools include diagnostic clinical criteria, family history, genetic prediction models, and tumor testing. Patients who are high risk based on screening should be referred for genetic testing.

Keywords

Lynch syndrome - familial adenomatous polyposis - Peutz-Jeghers syndrome

• References

• 1 Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59 (4) 225-249
• 2 Mecklin JP. Frequency of hereditary colorectal carcinoma. Gastroenterology 1987; 93 (5) 1021-1025
• 3 Ponz de Leon M, Sassatelli R, Sacchetti C, Zanghieri G, Scalmati A, Roncucci L. Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry. Cancer Res 1989; 49 (15) 4344-4348
• 4 Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology 2010; 138 (6) 2044-2058
• 5 Samowitz WS, Curtin K, Lin HH , et al. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 2001; 121 (4) 830-838
• 6 Papaemmanuil E, Carvajal-Carmona L, Sellick GS , et al; CORGI Consortium. Deciphering the genetics of hereditary non-syndromic colorectal cancer. Eur J Hum Genet 2008; 16 (12) 1477-1486
• 7 Gallagher DJ, Smith JD, Offit K, Stadler ZK. Diagnosing hereditary colorectal cancer. Clin Colorectal Cancer 2010; 9 (4) 205-211
• 8 Järvinen HJ, Aarnio M, Mustonen H , et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000; 118 (5) 829-834
• 9 de Jong AE, Hendriks YM, Kleibeuker JH , et al. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006; 130 (3) 665-671
• 10 Regula J, Rupinski M, Kraszewska E , et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006; 355 (18) 1863-1872
• 11 van Dijk DA, Oostindiër MJ, Kloosterman-Boele WM, Krijnen P, Vasen HF. ; Hereditary Tumor Study Group of the Comprehensive Cancer Centre West. Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data. Fam Cancer 2007; 6 (1) 131-134
• 12 Nielsen M, Joerink-van de Beld MC, Jones N , et al. Analysis of MUTYH genotypes and colorectal phenotypes in patients with MUTYH-associated polyposis. Gastroenterology 2009; 136 (2) 471-476
• 13 Jones N, Vogt S, Nielsen M , et al. Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH. Gastroenterology 2009; 137 (2) 489-494 , 494, e1, quiz 725–726
• 14 Gruber SB, Kohlmann W. The genetics of hereditary non-polyposis colorectal cancer. J Natl Compr Canc Netw 2003; 1 (1) 137-144
• 15 Rhyu MS. Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma. J Natl Cancer Inst 1996; 88 (5) 240-251
• 16 Chung DC, Rustgi AK. DNA mismatch repair and cancer. Gastroenterology 1995; 109 (5) 1685-1699
• 17 Lazar V, Grandjouan S, Bognel C , et al. Accumulation of multiple mutations in tumour suppressor genes during colorectal tumorigenesis in HNPCC patients. Hum Mol Genet 1994; 3 (12) 2257-2260
• 18 Hendriks YM, Wagner A, Morreau H , et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 2004; 127 (1) 17-25
• 19 Piñol V, Castells A, Andreu M , et al; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 2005; 293 (16) 1986-1994
• 20 Choi YH, Cotterchio M, McKeown-Eyssen G , et al. Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario. Hered Cancer Clin Pract 2009; 7 (1) 14
• 21 Lagerstedt Robinson K, Liu T, Vandrovcova J , et al. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst 2007; 99 (4) 291-299
• 22 Hampel H, Frankel WL, Martin E , et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005; 352 (18) 1851-1860
• 23 Wijnen JT, Vasen HF, Khan PM , et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998; 339 (8) 511-518
• 24 Hampel H, Frankel W, Panescu J , et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 2006; 66 (15) 7810-7817
• 25 Lindor NM, Rabe K, Petersen GM , et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005; 293 (16) 1979-1985
• 26 Mueller-Koch Y, Vogelsang H, Kopp R , et al. Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 2005; 54 (12) 1733-1740
• 27 Llor X, Pons E, Xicola RM , et al; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin Cancer Res 2005; 11 (20) 7304-7310
• 28 Valle L, Perea J, Carbonell P , et al. Clinicopathologic and pedigree differences in Amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 2007; 25 (7) 781-786
• 29 Jass JR. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol 2006; 12 (31) 4943-4950
• 30 Abdel-Rahman WM, Ollikainen M, Kariola R , et al. Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations. Oncogene 2005; 24 (9) 1542-1551
• 31 Shah NB, Lindor NM. Lower gastrointestinal tract cancer predisposition syndromes. Hematol Oncol Clin N Am 2010; 24: 1229-1252
• 32 Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993; 71 (3) 677-685
• 33 Watson P, Vasen HF, Mecklin JP, Järvinen H, Lynch HT. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med 1994; 96 (6) 516-520
• 34 Aarnio M, Mecklin JP, Aaltonen LA, Nyström-Lahti M, Järvinen HJ. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995; 64 (6) 430-433
• 35 Kastrinos F, Mukherjee B, Tayob N , et al. Risk of pancreatic cancer in families with Lynch syndrome. JAMA 2009; 302 (16) 1790-1795
• 36 Vasen HF, Möslein G, Alonso A , et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007; 44 (6) 353-362
• 37 Hendriks YM, Wagner A, Morreau H , et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 2004; 127 (1) 17-25
• 38 Broaddus RR, Lynch HT, Chen LM , et al. Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma. Cancer 2006; 106 (1) 87-94
• 39 Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on hereditary nonpolyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34 (5) 424-425
• 40 Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116 (6) 1453-1456
• 41 Rodriguez-Bigas MA, Boland CR, Hamilton SR , et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda Guidelines. J Natl Cancer Inst 1997; 89 (23) 1758-1762
• 42 Syngal S, Fox EA, Eng C, Kolodner RD, Garber JE. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 2000; 37 (9) 641-645
• 43 Umar A, Boland CR, Terdiman JP , et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96 (4) 261-268
• 44 Hampel H, Frankel WL, Martin E , et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005; 352 (18) 1851-1860
• 45 Grover S, Syngal S. Risk assessment, genetic testing, and management of Lynch syndrome. J Natl Compr Canc Netw 2010; 8 (1) 98-105
• 46 Hampel H, Frankel W, Panescu J , et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 2006; 66 (15) 7810-7817
• 47 Barnetson RA, Tenesa A, Farrington SM , et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 2006; 354 (26) 2751-2763
• 48 Tenesa A, Farrington SM, Prendergast JG , et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 2008; 40 (5) 631-637
• 49 Tomlinson IP, Webb E, Carvajal-Carmona L , et al; CORGI Consortium; EPICOLON Consortium. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 2008; 40 (5) 623-630
• 50 Balmaña J, Stockwell DH, Steyerberg EW , et al. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 2006; 296 (12) 1469-1478
• 51 Chen S, Wang W, Lee S , et al; Colon Cancer Family Registry. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 2006; 296 (12) 1479-1487
• 52 Balaguer F, Balmaña J, Castellví-Bel S , et al; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients. Gastroenterology 2008; 134 (1) 39-46
• 53 Grover S, Stoffel EM, Mercado RC , et al. Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome. J Clin Oncol 2009; 27 (24) 3981-3986
• 54 Suspiro A, Fidalgo P, Cravo M , et al. The Muir-Torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation. Am J Gastroenterol 1998; 93 (9) 1572-1574
• 55 Kruse R, Rütten A, Lamberti C , et al. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet 1998; 63 (1) 63-70
• 56 South CD, Hampel H, Comeras I, Westman JA, Frankel WL, de la Chapelle A. The frequency of Muir-Torre syndrome among Lynch syndrome families. J Natl Cancer Inst 2008; 100 (4) 277-281
• 57 Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006; 101 (2) 385-398
• 58 Rozen P, Macrae F. Familial adenomatous polyposis: the practical applications of clinical and molecular screening. Fam Cancer 2006; 5 (3) 227-235
• 59 Lipton L, Tomlinson I. The genetics of FAP and FAP-like syndromes. Fam Cancer 2006; 5 (3) 221-226
• 60 Houlston R, Crabtree M, Phillips R, Crabtree M, Tomlinson I. Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes. Gut 2001; 48 (1) 1-5
• 61 Pérez Segura P, Guillén Ponce C, Ramón y Cajal T, Serrano Blanch R, Aranda E. TTD consensus document on the diagnosis and management of hereditary colorectal cancer. Clin Transl Oncol 2010; 12 (5) 356-366
• 62 Lal G, Gallinger S. Familial adenomatous polyposis. Semin Surg Oncol 2000; 18 (4) 314-323
• 63 Berk T, Cohen Z, Bapat B, Gallinger S. Negative genetic test result in familial adenomatous polyposis: clinical screening implications. Dis Colon Rectum 1999; 42 (3) 307-310 , discussion 310–312
• 64 Petersen GM, Slack J, Nakamura Y. Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology 1991; 100 (6) 1658-1664
• 65 Rustin RB, Jagelman DG, McGannon E, Fazio VW, Lavery IC, Weakley FL. Spontaneous mutation in familial adenomatous polyposis. Dis Colon Rectum 1990; 33 (1) 52-55
• 66 Zippel DB, Temple WJ. When is a neoplasm not a neoplasm? When it is a desmoid. J Surg Oncol 2007; 95 (3) 190-191
• 67 Sturt NJ, Clark SK. Current ideas in desmoid tumours. Fam Cancer 2006; 5 (3) 275-285 , discussion 287–288
• 68 Bertario L, Russo A, Sala P , et al; Hereditary Colorectal Tumours Registry. Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 2001; 95 (2) 102-107
• 69 Lynch HT, Fitzgibbons Jr R. Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review. Am J Gastroenterol 1996; 91 (12) 2598-2601
• 70 Eccles DM, van der Luijt R, Breukel C , et al. Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. Am J Hum Genet 1996; 59 (6) 1193-1201
• 71 Chen CS, Phillips KD, Grist S , et al. Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer. Fam Cancer 2006; 5 (4) 397-404
• 72 Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990; 33 (8) 639-642
• 73 Church JM, McGannon E, Hull-Boiner S , et al. Gastroduodenal polyps in patients with familial adenomatous polyposis. Dis Colon Rectum 1992; 35 (12) 1170-1173
• 74 Kadmon M, Tandara A, Herfarth C. Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg Polyposis Register. Int J Colorectal Dis 2001; 16 (2) 63-75
• 75 Groves CJ, Saunders BP, Spigelman AD, Phillips RK. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 2002; 50 (5) 636-641
• 76 Park JG, Park KJ, Ahn YO , et al. Risk of gastric cancer among Korean familial adenomatous polyposis patients. Report of three cases. Dis Colon Rectum 1992; 35 (10) 996-998
• 77 Brosens LA, Keller JJ, Offerhaus GJ, Goggins M, Giardiello FM. Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut 2005; 54 (7) 1034-1043
• 78 Cetta F, Mazzarella L, Bon G, Zuckermann M, Casorelli A, Nounga H. Genetic alterations in hepatoblastoma and hepatocellular carcinoma associated with familial adenomatous polyposis. Med Pediatr Oncol 2003; 41 (5) 496-497
• 79 Herraiz M, Barbesino G, Faquin W , et al. Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. Clin Gastroenterol Hepatol 2007; 5 (3) 367-373
• 80 Hamilton SR, Liu B, Parsons RE , et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995; 332 (13) 839-847
• 81 Knudsen AL, Bisgaard ML, Bülow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer 2003; 2 (1) 43-55
• 82 Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet 2001; 10 (7) 721-733
• 83 Näthke IS. The adenomatous polyposis coli protein: the Achilles heel of the gut epithelium. Annu Rev Cell Dev Biol 2004; 20: 337-366
• 84 Sieber O, Segditsas S, Knudsen A , et al. Disease severity and genetic pathways in attenuated FAP vary greatly but depend on the site of the germline mutation. Gut 2006; 55: 1440-1448
• 85 Bertario L, Russo A, Sala P , et al; Hereditary Colorectal Tumor Registry. Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol 2003; 21 (9) 1698-1707
• 86 Caspari R, Olschwang S, Friedl W , et al. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995; 4 (3) 337-340
• 87 Enomoto M, Konishi M, Iwama T, Utsunomiya J, Sugihara KI, Miyaki M. The relationship between frequencies of extracolonic manifestations and the position of APC germline mutation in patients with familial adenomatous polyposis. Jpn J Clin Oncol 2000; 30 (2) 82-88
• 88 Ficari F, Cama A, Valanzano R , et al. APC gene mutations and colorectal adenomatosis in familial adenomatous polyposis. Br J Cancer 2000; 82 (2) 348-353
• 89 Brensinger JD, Laken SJ, Luce MC , et al. Variable phenotype of familial adenomatous polyposis in pedigrees with 3′ mutation in the APC gene. Gut 1998; 43 (4) 548-552
• 90 Nieuwenhuis MH, Vasen HF. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol Hematol 2007; 61 (2) 153-161
• 91 Lefevre JH, Parc Y, Svrcek M , et al. APC, MYH, and the correlation genotype-phenotype in colorectal polyposis. Ann Surg Oncol 2009; 16 (4) 871-877
• 92 Al-Tassan N, Chmiel NH, Maynard J , et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet 2002; 30 (2) 227-232
• 93 Lipton L, Tomlinson I. The multiple colorectal adenoma phenotype and MYH, a base excision repair gene. Clin Gastroenterol Hepatol 2004; 2 (8) 633-638
• 94 Holter S, Gallinger S. MUTYH-associated polyposis. In: Potter J, Lindor N, eds. Genetics of colorectal cancer. New York, NY: Springer Science Business Media; 2009: 173-181
• 95 Cheadle JP, Sampson JR. MUTYH-associated polyposis—from defect in base excision repair to clinical genetic testing. DNA Repair (Amst) 2007; 6 (3) 274-279
• 96 Croitoru ME, Cleary SP, Di Nicola N , et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 2004; 96 (21) 1631-1634
• 97 Nielsen M, Franken PF, Reinards TH , et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet 2005; 42 (9) e54
• 98 Halford SE, Rowan AJ, Lipton L , et al. Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol 2003; 162 (5) 1545-1548
• 99 Okamoto K, Toyokuni S, Uchida K , et al. Formation of 8-hydroxy-20-deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in human renal-cell carcinoma. Int J Cancer 1994; 58: 825-829
• 100 Malins DC, Haimanot R. Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res 1991; 51 (19) 5430-5432
• 101 Jaruga P, Zastawny TH, Skokowski J, Dizdaroglu M, Olinski R. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett 1994; 341 (1) 59-64
• 102 DeMarzo AM, Nelson WG, Isaacs WB, Epstein JI. Pathological and molecular aspects of prostate cancer. Lancet 2003; 361 (9361) 955-964
• 103 Charbonnier F, Olschwang S, Wang Q , et al. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res 2002; 62 (3) 848-853
• 104 Sampson JR, Dolwani S, Jones S , et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 2003; 362 (9377) 39-41
• 105 Sieber OM, Lipton L, Crabtree M , et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003; 348 (9) 791-799
• 106 Jenkins MA, Croitoru ME, Monga N , et al. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol Biomarkers Prev 2006; 15 (2) 312-314
• 107 Farrington SM, Tenesa A, Barnetson R , et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet 2005; 77 (1) 112-119
• 108 Webb EL, Rudd MF, Houlston RS. Colorectal cancer risk in monoallelic carriers of MYH variants. Am J Hum Genet 2006; 79 (4) 768-771 , author reply 771–772
• 109 Lubbe SJ, Di Bernardo MC, Chandler IP, Houlston RS. Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol 2009; 27 (24) 3975-3980
• 110 Avezzù A, Agostini M, Pucciarelli S , et al. The role of MYH gene in genetic predisposition to colorectal cancer: another piece of the puzzle. Cancer Lett 2008; 268 (2) 308-313
• 111 Nielsen M, Poley JW, Verhoef S , et al. Duodenal carcinoma in MUTYH-associated polyposis. J Clin Pathol 2006; 59 (11) 1212-1215
• 112 Boardman LA. Heritable colorectal cancer syndromes: recognition and preventive management. Gastroenterol Clin North Am 2002; 31 (4) 1107-1131
• 113 Anyanwu SN. Sporadic Peutz-Jeghers syndrome in a Nigerian. Cent Afr J Med 1999; 45 (7) 182-184
• 114 Yoon KA, Ku JL, Choi HS , et al. Germline mutations of the STK11 gene in Korean Peutz-Jeghers syndrome patients. Br J Cancer 2000; 82 (8) 1403-1406
• 115 Hearle N, Schumacher V, Menko FH , et al. Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 2006; 12 (10) 3209-3215
• 116 Mehenni H, Resta N, Park JG, Miyaki M, Guanti G, Costanza MC. Cancer risks in LKB1 germline mutation carriers. Gut 2006; 55 (7) 984-990
• 117 Olschwang S, Boisson C, Thomas G. Peutz-Jeghers families unlinked to STK11/LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinoma. J Med Genet 2001; 38 (6) 356-360
• 118 Aaltonen L. Peutz-Jeghers syndrome. In: Vogelstein B, Kinzler K, eds. The genetic basis of human cancer. New York, NY: McGraw-Hill; 2002: 337-41
• 119 Riegert-Johnson D, Boardman L. Peutz-Jeghers syndrome. In: Potter J, Lindor N, eds. Genetics of colorectal cancer. New York, NY: Springer; 2009: 193-198
• 120 Amos CI, Keitheri-Cheteri MB, Sabripour M , et al. Genotype-phenotype correlations in Peutz-Jeghers syndrome. J Med Genet 2004; 41 (5) 327-333
• 121 Rowan A, Churchman M, Jefferey R, Hanby A, Poulsom R, Tomlinson I. In situ analysis of LKB1/STK11 mRNA expression in human normal tissues and tumours. J Pathol 2000; 192 (2) 203-206
• 122 Boudeau J, Baas AF, Deak M , et al. MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J 2003; 22 (19) 5102-5114
• 123 Ylikorkala A, Avizienyte E, Tomlinson IP , et al. Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum Mol Genet 1999; 8 (1) 45-51
• 124 Karuman P, Gozani O, Odze RD , et al. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell 2001; 7 (6) 1307-1319
• 125 Gruber SB, Entius MM, Petersen GM , et al. Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res 1998; 58 (23) 5267-5270
• 126 Flageole H, Raptis S, Trudel JL, Lough JO. Progression toward malignancy of hamartomas in a patient with Peutz-Jeghers syndrome: case report and literature review. Can J Surg 1994; 37 (3) 231-236
• 127 Nakau M, Miyoshi H, Seldin MF, Imamura M, Oshima M, Taketo MM. Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. Cancer Res 2002; 62 (16) 4549-4553
• 128 Jishage K, Nezu J, Kawase Y , et al. Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis. Proc Natl Acad Sci U S A 2002; 99 (13) 8903-8908
• 129 Hemminki A, Markie D, Tomlinson I , et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998; 391 (6663) 184-187
• 130 Jenne DE, Reimann H, Nezu J , et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998; 18 (1) 38-43
• 131 Giardiello FM, Hamilton SR, Kern SE , et al. Colorectal neoplasia in juvenile polyposis or juvenile polyps. Arch Dis Child 1991; 66 (8) 971-975
• 132 Aaltonen L, Jass J, Howe J. Juvenile polyposis. In: Hamilton S, Aaltonen L, eds. Pathology and genetics. Tumours of the digestive system. Lyon, France: IARC Press; 2000: 130-132
• 133 Burt RW, Bishop DT, Lynch HT, Rozen P, Winawer SJ. ; WHO Collaborating Centre for the Prevention of Colorectal Cancer. Risk and surveillance of individuals with heritable factors for colorectal cancer. Bull World Health Organ 1990; 68 (5) 655-665
• 134 Nugent KP, Talbot IC, Hodgson SV, Phillips RK. Solitary juvenile polyps: not a marker for subsequent malignancy. Gastroenterology 1993; 105 (3) 698-700
• 135 Brosens LA, van Hattem A, Hylind LM , et al. Risk of colorectal cancer in juvenile polyposis. Gut 2007; 56 (7) 965-967
• 136 Merg A, Lynch HT, Lynch JF, Howe JR. Hereditary colorectal cancer-part II. Curr Probl Surg 2005; 42 (5) 267-333
• 137 Roth S, Sistonen P, Salovaara R , et al. SMAD genes in juvenile polyposis. Genes Chromosomes Cancer 1999; 26 (1) 54-61
• 138 Brosens LA, van Hattem WA, Jansen M, de Leng WW, Giardiello FM, Offerhaus GJ. Gastrointestinal polyposis syndromes. Curr Mol Med 2007; 7 (1) 29-46
• 139 Howe JR, Sayed MG, Ahmed AF , et al. The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet 2004; 41 (7) 484-491
• 140 Höfting I, Pott G, Stolte M. [The syndrome of juvenile polyposis]. Leber Magen Darm 1993; 23 (3) 107-108 , 111–112
• 141 Chow E, Macrae F. A review of juvenile polyposis syndrome. J Gastroenterol Hepatol 2005; 20 (11) 1634-1640
• 142 Sayed MG, Ahmed AF, Ringold JR , et al. Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol 2002; 9 (9) 901-906
• 143 Pyatt RE, Pilarski R, Prior TW. Mutation screening in juvenile polyposis syndrome. J Mol Diagn 2006; 8 (1) 84-88
• 144 Kim BG, Li C, Qiao W , et al. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 2006; 441 (7096) 1015-1019
• 145 Kinzler KW, Vogelstein B. Landscaping the cancer terrain. Science 1998; 280 (5366) 1036-1037
• 146 Friedl W, Uhlhaas S, Schulmann K , et al. Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers. Hum Genet 2002; 111 (1) 108-111
• 147 Handra-Luca A, Condroyer C, de Moncuit C , et al. Vessels' morphology in SMAD4 and BMPR1A-related juvenile polyposis. Am J Med Genet A 2005; 138A (2) 113-117
• 148 Sweet K, Willis J, Zhou XP , et al. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA 2005; 294 (19) 2465-2473
• 149 Blanco FJ, Santibanez JF, Guerrero-Esteo M, Langa C, Vary CP, Bernabeu C. Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex. J Cell Physiol 2005; 204 (2) 574-584
• 150 Howe JR, Haidle JL, Lal G , et al. ENG mutations in MADH4/BMPR1A mutation negative patients with juvenile polyposis. Clin Genet 2007; 71 (1) 91-92
• 151 Zbuk KM, Eng C. Hamartomatous polyposis syndromes. Nat Clin Pract Gastroenterol Hepatol 2007; 4 (9) 492-502
• 152 Dahia PL. PTEN, a unique tumor suppressor gene. Endocr Relat Cancer 2000; 7 (2) 115-129
• 153 Burt R, Neklason DW. Genetic testing for inherited colon cancer. Gastroenterology 2005; 128 (6) 1696-1716
• 154 Marsh DJ, Dahia PL, Zheng Z , et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 1997; 16 (4) 333-334
• 155 Liaw D, Marsh DJ, Li J , et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997; 16 (1) 64-67
• 156 Kinzler KW, Vogelstein B. Landscaping the cancer terrain. Science 1998; 280 (5366) 1036-1037
• 157 Gryfe R. Inherited colorectal cancer syndromes. Clin Colon Rectal Surg 2009; 22 (4) 198-208
• 158 Cronkhite Jr LW, Canada WJ. Generalized gastrointestinal polyposis; an unusual syndrome of polyposis, pigmentation, alopecia and onychotrophia. N Engl J Med 1955; 252 (24) 1011-1015
• 159 Riegert-Johnson DL, Osborn N, Smyrk T, Boardman LA. Cronkhite-Canada syndrome hamartomatous polyps are infiltrated with IgG4 plasma cells. Digestion 2007; 75 (2-3) 96-97
• 160 Goto A. Cronkhite-Canada syndrome: epidemiological study of 110 cases reported in Japan. Nihon Geka Hokan 1995; 64 (1) 3-14
• 161 Ward EM, Wolfsen HC. Review article: the non-inherited gastrointestinal polyposis syndromes. Aliment Pharmacol Ther 2002; 16 (3) 333-342
• 162 Sampson JE, Harmon ML, Cushman M, Krawitt EL. Corticosteroid-responsive Cronkhite-Canada syndrome complicated by thrombosis. Dig Dis Sci 2007; 52 (4) 1137-1140
• 163 Takeuchi Y, Yoshikawa M, Tsukamoto N , et al. Cronkhite-Canada syndrome with colon cancer, portal thrombosis, high titer of antinuclear antibodies, and membranous glomerulonephritis. J Gastroenterol 2003; 38 (8) 791-795
• 164 Qiao M, Lei Z, Nai-Zhong H, Jian-Ming X. Cronkhite-Canada syndrome with hypothyroidism. South Med J 2005; 98 (5) 575-576
• 165 Daniel ES, Ludwig SL, Lewin KJ, Ruprecht RM, Rajacich GM, Schwabe AD. The Cronkhite-Canada Syndrome. An analysis of clinical and pathologic features and therapy in 55 patients. Medicine (Baltimore) 1982; 61 (5) 293-309
• 166 Blonski WC, Furth EE, Kinosian BP, Compher C, Metz DC. A case of Cronkhite-Canada syndrome with taste disturbance as a leading complaint. Digestion 2005; 71 (4) 201-205
• 167 Samoha S, Arber N. Cronkhite-Canada syndrome. Digestion 2005; 71 (4) 199-200
• 168 Yashiro M, Kobayashi H, Kubo N, Nishiguchi Y, Wakasa K, Hirakawa K. Cronkhite-Canada syndrome containing colon cancer and serrated adenoma lesions. Digestion 2004; 69 (1) 57-62
• 169 Anderson RD, Patel R, Hamilton JK, Boland CR. Cronkhite-Canada syndrome presenting as eosinophilic gastroenteritis. Proc (Bayl Univ Med Cent) 2006; 19 (3) 209-212 (Baylor University Medical Center)
• 170 Mönkemüller K, Neumann H, Evert M. Cronkhite-Canada syndrome: panendoscopic characterization with esophagogastroduodenoscopy, endoscopic ultrasound, colonoscopy, and double balloon enteroscopy. Clin Gastroenterol Hepatol 2008; 6 (10) A26
• 171 Chadalavada R, Brown DK, Walker AN, Sedghi S. Cronkhite-Canada syndrome: sustained remission after corticosteroid treatment. Am J Gastroenterol 2003; 98 (6) 1444-1446
• 172 Ward E, Wolfsen HC, Ng C. Medical management of Cronkhite-Canada syndrome. South Med J 2002; 95 (2) 272-274
• 173 Okamoto K, Isomoto H, Shikuwa S, Nishiyama H, Ito M, Kohno S. A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen. Digestion 2008; 78 (2-3) 82-87
• 174 Kao KT, Patel JK, Pampati V. Cronkhite-Canada syndrome: a case report and review of literature. Gastroenterol Res Pract 2009; (2009) 619378